Phase 3 Transarterial Chemoembolization Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular CarcinomaApatinibCamrelizumab+1 more
Guohui Xu101 enrolled1 locationNCT06485466
Recruiting
Phase 3
Adjuvant TACE in HCC With High-risk Recurrence Factors
Hepatocellular CarcinomaAdjuvantTransarterial Chemoembolization
Guangxi Medical University442 enrolled1 locationNCT07417397